Benneth Ben-Azu

Benneth Ben-Azu


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in International Immunopharmacology
Verified
Journal Article
Closed access
BBBenneth Ben-Azu
Benneth Ben-Azu
AAAdegbuyi Oladele Aderibigbe
Adegbuyi Oladele Aderibigbe
AAAbayomi Mayowa Ajayi
Abayomi Mayowa Ajayi
AEAya-Ebi Okubo Eneni
Aya-Ebi Okubo Eneni
IOItivere Adrian Omogbiya
Itivere Adrian Omogbiya
EIEzekiel O. Iwalewa
Ezekiel O. Iwalewa

1 January 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
BBBenneth Ben-Azu
Benneth Ben-Azu
ENEkene Enekabokom Nwoke
Ekene Enekabokom Nwoke
AAAdegbuyi Oladele Aderibigbe
Adegbuyi Oladele Aderibigbe
IOItivere Adrian Omogbiya
Itivere Adrian Omogbiya
AAAbayomi Ajayi
Abayomi Ajayi
EIEzekiel O. Iwalewa
Ezekiel O. Iwalewa
Flavonoids are naturally occurring bioactive phytochemical metabolites widely known to prevent and suppress several human diseases, and are important sources of therapeutic compounds from plants. Evidence derived from previous studies suggests that naringin, a neuroactive flavonoid possess functional beneficial neurobehavioral effects including anxiolytic, antidepressant and memory enhancing properties. However, literature search revealed that no studies have been carried out to evaluate the possible biochemical mechanisms involved in the neurobehavioral property of naringin alone following repeated treatment. Hence, this study was designed to evaluate the possible neuro-biochemical mechanisms involved in the neurobehavioral property of naringin following repeated administration in mice. The effects of naringin (2.5, 5 and 10 mg/kg), diazepam (2 mg/kg), imipramine (15 mg/kg) and donepezil (1 mg/kg) or vehicle on neurobehavioral and biochemical effects were evaluated in mice following repeated intraperitoneal injection for 7 consecutive days. Neurobehavioral activities consisting of open-field (locomotor), elevated-plus maze (anxiolytic), forced swim and social interaction (antidepressant and social preference), and Y-maze (memory enhancing) tests were assessed. Thereafter, brains levels of biomarkers of oxidative, nitrosative and cholinergic parameters were determined. Repeated treatment with naringin produced increased locomotor activity, and demonstrated antidepressant-like effects evidenced by decreased immobility time in forced swim test and increased % social preference in the social interaction test relative to controls. Also, naringin induced anxiolytic-like effect and increased cognitive performance in mice. Mechanistically, naringin significantly increased the activities of superoxide dismutase and catalase, and glutathione concentration relative to vehicle-controls. However, naringin significantly decreased malondialdehyde and nitrite contents, and reduced brain acetylcholinesterase activity in mice brains in a significant manner relative to controls. Taken together, these findings suggest that treatment with naringin might be useful to produce functional behavioral effects via mechanisms related to enhancement of cholinergic transmission, antioxidant defense systems, inhibition of lipid peroxidation and nitrosative processes.

1 September 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
BBBenneth Ben-Azu
Benneth Ben-Azu
AAAdegbuyi Oladele Aderibigbe
Adegbuyi Oladele Aderibigbe
IOItivere Adrian Omogbiya
Itivere Adrian Omogbiya
AAAbayomi Ajayi
Abayomi Ajayi
OOOlatunde Owoeye
Olatunde Owoeye
EIEzekiel O. Iwalewa
Ezekiel O. Iwalewa

1 May 2018 in Brain Research Bulletin
Verified
Journal Article
Closed access
BBBenneth Ben-Azu
Benneth Ben-Azu
AAAdegbuyi Oladele Aderibigbe
Adegbuyi Oladele Aderibigbe
AAAbayomi Ajayi
Abayomi Ajayi
AEAya-Ebi Okubo Eneni
Aya-Ebi Okubo Eneni
SUSolomon Umukoro
Solomon Umukoro
EIEzekiel O. Iwalewa
Ezekiel O. Iwalewa

28 June 2018 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
BBBenneth Ben-Azu
Benneth Ben-Azu
AAAdegbuyi Oladele Aderibigbe
Adegbuyi Oladele Aderibigbe
AEAya-Ebi Okubo Eneni
Aya-Ebi Okubo Eneni
AAAbayomi Mayowa Ajayi
Abayomi Mayowa Ajayi
SUSolomon Umukoro
Solomon Umukoro
EIEzekiel O. Iwalewa
Ezekiel O. Iwalewa

1 September 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
SUSolomon Umukoro
Solomon Umukoro
HKHassanat Adeola Kalejaye
Hassanat Adeola Kalejaye
BBBenneth Ben-Azu
Benneth Ben-Azu
AAAbayomi Ajayi
Abayomi Ajayi